Last 12 months
Inside the activity.
0 purchase rows · 29 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 9 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 19, 2018 Filed Feb 22, 2018 00:37 UTC |
Klug Robert AVP, Corporate Controller
|
GrantNon-Qualifed Stock Option (right to buy) · Derivative | 6,176 | $0.00 Strike: $103.57 | $0.00 |
DisclosureSEC source: 0001022079-18-000030 · wf-form4_151925981045136.xml · derivative · entry 2 Klug Robert A · CIK 0001347843 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,176 Underlying: Common Stock · 6,176 shares Expires 2028-02-19 F3 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 19, 2018 Filed Feb 22, 2018 00:37 UTC |
Klug Robert AVP, Corporate Controller
|
GrantCommon Stock | 541 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-18-000030 · wf-form4_151925981045136.xml · nonDerivative · entry 1 Klug Robert A · CIK 0001347843 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,180 F1 · shares: Represents an award of restricted share units. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| February 19, 2018 Filed Feb 22, 2018 00:34 UTC |
Davis J. E.EVP, General Diagnostics
|
GrantNon-Qualifed Stock Option (right to buy) · Derivative | 48,555 | $0.00 Strike: $103.57 | $0.00 |
DisclosureSEC source: 0001022079-18-000028 · wf-form4_151925962760273.xml · derivative · entry 2 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,555 Underlying: Common Stock · 48,555 shares Expires 2028-02-19 F3 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 19, 2018 Filed Feb 22, 2018 00:34 UTC |
Davis J. E.EVP, General Diagnostics
|
GrantCommon Stock | 4,249 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-18-000028 · wf-form4_151925962760273.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,345 F1 · shares: Represents an award of restricted share units. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| February 19, 2018 Filed Feb 22, 2018 00:32 UTC |
Cunningham EverettSVP, Commercial
|
GrantNon-Qualifed Stock Option (right to buy) · Derivative | 33,103 | $0.00 Strike: $103.57 | $0.00 |
DisclosureSEC source: 0001022079-18-000026 · wf-form4_151925955726503.xml · derivative · entry 3 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,103 Underlying: Common Stock · 33,103 shares Expires 2028-02-19 F4 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 19, 2018 Filed Feb 22, 2018 00:32 UTC |
Cunningham EverettSVP, Commercial
|
GrantCommon Stock | 2,897 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-18-000026 · wf-form4_151925955726503.xml · nonDerivative · entry 1 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,472 F1 · shares: Represents an award of restricted share units. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| February 19, 2018 Filed Feb 22, 2018 00:31 UTC |
Cohen Jon RSVP & Group Exec. Diag. Sol.
|
GrantNon-Qualifed Stock Option (right to buy) · Derivative | 27,589 | $0.00 Strike: $103.57 | $0.00 |
DisclosureSEC source: 0001022079-18-000024 · wf-form4_151925945955674.xml · derivative · entry 2 Cohen Jon R · CIK 0001477972 · SVP & Group Exec. Diag. Sol. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,589 Underlying: Common Stock · 27,589 shares Expires 2028-02-19 F2 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 19, 2018 Filed Feb 22, 2018 00:31 UTC |
Cohen Jon RSVP & Group Exec. Diag. Sol.
|
GrantCommon Stock | 2,414 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-18-000024 · wf-form4_151925945955674.xml · nonDerivative · entry 1 Cohen Jon R · CIK 0001477972 · SVP & Group Exec. Diag. Sol. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,097 F1 · shares: Represents an award of restricted share units. Read SEC document |
| February 19, 2018 Filed Feb 22, 2018 00:30 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, President and CEO
|
GrantNon-Qualifed Stock Option (right to buy) · Derivative | 171,061 | $0.00 Strike: $103.57 | $0.00 |
DisclosureSEC source: 0001022079-18-000022 · wf-form4_151925938624594.xml · derivative · entry 2 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,061 Underlying: Common Stock · 171,061 shares Expires 2028-02-19 F2 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 19, 2018 Filed Feb 22, 2018 00:30 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, President and CEO
|
GrantCommon Stock | 14,966 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-18-000022 · wf-form4_151925938624594.xml · nonDerivative · entry 1 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,082 F1 · shares: Represents an award of restricted share units. Read SEC document |
| February 19, 2018 Filed Feb 22, 2018 00:26 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
GrantNon-Qualifed Stock Option (right to buy) · Derivative | 28,690 | $0.00 Strike: $103.57 | $0.00 |
DisclosureSEC source: 0001022079-18-000020 · wf-form4_151925918194420.xml · derivative · entry 3 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,690 Underlying: Common Stock · 28,690 shares Expires 2028-02-19 F4 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 19, 2018 Filed Feb 22, 2018 00:26 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
GrantCommon Stock | 2,511 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-18-000020 · wf-form4_151925918194420.xml · nonDerivative · entry 1 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,888 F1 · shares: Represents an award of restricted share units. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| February 19, 2018 Filed Feb 22, 2018 00:23 UTC |
Doherty Catherine T.SVP, Group Exec. Clin. Fran.
|
GrantNon-Qualifed Stock Option (right to buy) · Derivative | 33,103 | $0.00 Strike: $103.57 | $0.00 |
DisclosureSEC source: 0001022079-18-000018 · wf-form4_151925900684795.xml · derivative · entry 3 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,103 Underlying: Common Stock · 33,103 shares Expires 2028-02-19 F3 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 19, 2018 Filed Feb 22, 2018 00:23 UTC |
Doherty Catherine T.SVP, Group Exec. Clin. Fran.
|
GrantCommon Stock | 2,897 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-18-000018 · wf-form4_151925900684795.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,312 F1 · shares: Represents an award of restricted share units. Read SEC document |
| February 19, 2018 Filed Feb 22, 2018 00:19 UTC |
EGLINTON MANNER CARRIESVP, Advanced Diagnostics
|
GrantNon-Qualifed Stock Option (right to buy) · Derivative | 38,623 | $0.00 Strike: $103.57 | $0.00 |
DisclosureSEC source: 0001022079-18-000016 · wf-form4_151925878152355.xml · derivative · entry 2 EGLINTON MANNER CARRIE · CIK 0001696776 · SVP, Advanced Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,623 Underlying: Common Stock · 38,623 shares Expires 2028-02-19 F2 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 19, 2018 Filed Feb 22, 2018 00:19 UTC |
EGLINTON MANNER CARRIESVP, Advanced Diagnostics
|
GrantCommon Stock | 3,380 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-18-000016 · wf-form4_151925878152355.xml · nonDerivative · entry 1 EGLINTON MANNER CARRIE · CIK 0001696776 · SVP, Advanced Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,661 F1 · shares: Represents an award of restricted share units. Read SEC document |
| January 29, 2018 Filed Jan 31, 2018 21:33 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, President and CEO
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 106,840 | $58.18 Strike: $58.18 | $6,215,417.00 |
DisclosureSEC source: 0001022079-18-000011 · wf-form4_151743439318187.xml · derivative · entry 3 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 106,840 shares Expires 2022-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 3, 2017. F2 · derivative.exercise_date: The options vested in three equal annual installments beginning with the first on May 1, 2013, the second on May 1, 2014 and the final on May 1, 2015. Read SEC document |
| January 29, 2018 Filed Jan 31, 2018 21:33 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, President and CEO
|
SaleCommon Stock | 106,840 | $107.00 | $11,431,880.00 |
DisclosureSEC source: 0001022079-18-000011 · wf-form4_151743439318187.xml · nonDerivative · entry 2 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,116 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 3, 2017. Read SEC document |
| January 29, 2018 Filed Jan 31, 2018 21:33 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, President and CEO
|
Exercise / conversionCommon Stock | 106,840 | $58.18 | $6,215,417.00 |
DisclosureSEC source: 0001022079-18-000011 · wf-form4_151743439318187.xml · nonDerivative · entry 1 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,956 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 3, 2017. Read SEC document |
| January 24, 2018 Filed Jan 26, 2018 21:43 UTC |
Doherty Catherine T.SVP, Group Exec. Clin. Fran.
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 21,294 | $52.17 Strike: $52.17 | $1,110,801.51 |
DisclosureSEC source: 0001022079-18-000008 · wf-form4_151700297271754.xml · derivative · entry 4 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,294 shares Expires 2024-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 27, 2017. F3 · derivative.exercise_date: The options vested in three equal annual installments beginning with the first on February 13, 2015, the second on February 13, 2016 and the final on February 13, 2017. Read SEC document |
| January 24, 2018 Filed Jan 26, 2018 21:43 UTC |
Doherty Catherine T.SVP, Group Exec. Clin. Fran.
|
SaleCommon Stock | 21,294 | $104.00 | $2,214,576.00 |
DisclosureSEC source: 0001022079-18-000008 · wf-form4_151700297271754.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,415 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 27, 2017. Read SEC document |
| January 24, 2018 Filed Jan 26, 2018 21:43 UTC |
Doherty Catherine T.SVP, Group Exec. Clin. Fran.
|
Exercise / conversionCommon Stock | 21,294 | $52.17 | $1,110,801.51 |
DisclosureSEC source: 0001022079-18-000008 · wf-form4_151700297271754.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,709 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 27, 2017. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 21:35 UTC |
RING TIMOTHY MDirector
|
GrantPhantom Stock Units · Derivative | 312 | $98.73 Strike: $0.00 | $30,802.20 |
DisclosureSEC source: 0001022079-18-000006 · wf-form4_151510170095065.xml · derivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,206.081 Underlying: Common Stock · 312 shares Expires not disclosed F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F2 · balance_after: Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 21:34 UTC |
Davis J. E.EVP, General Diagnostics
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 63,880 | $52.17 Strike: $52.17 | $3,332,300.20 |
DisclosureSEC source: 0001022079-18-000005 · wf-form4_151510165968965.xml · derivative · entry 3 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 63,880 shares Expires 2024-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 28, 2017. F4 · derivative.exercise_date: The options vested in three equal annual installments beginning with the first on February 13, 2015, the second on February 13, 2016 and the final on February 13, 2017. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 21:34 UTC |
Davis J. E.EVP, General Diagnostics
|
SaleCommon Stock | 63,880 | $98.68 | $6,303,359.00 |
DisclosureSEC source: 0001022079-18-000005 · wf-form4_151510165968965.xml · nonDerivative · entry 2 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,053 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 28, 2017. F2 · price: This transaction was executed in multiple trades at prices ranging from $98.35 to $99.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 21:34 UTC |
Davis J. E.EVP, General Diagnostics
|
Exercise / conversionCommon Stock | 63,880 | $52.17 | $3,332,300.20 |
DisclosureSEC source: 0001022079-18-000005 · wf-form4_151510165968965.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,423 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 28, 2017. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 21:33 UTC |
EGLINTON MANNER CARRIESVP, Advanced Diagnostics
|
Tax withholdingCommon Stock | 2,256 | $99.12 | $223,614.72 |
DisclosureSEC source: 0001022079-18-000004 · wf-form4_151510161657515.xml · nonDerivative · entry 1 EGLINTON MANNER CARRIE · CIK 0001696776 · SVP, Advanced Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,281 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| October 13, 2017 Filed Oct 17, 2017 20:36 UTC |
Klug Robert AVP, Corporate Controller
|
Tax withholdingCommon Stock | 9 | $91.10 | $819.90 |
DisclosureSEC source: 0001022079-17-000186 · wf-form4_150827255798832.xml · nonDerivative · entry 1 Klug Robert A · CIK 0001347843 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,515 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 21:02 UTC |
RING TIMOTHY MDirector
|
GrantPhantom Stock Units · Derivative | 330 | $93.52 Strike: $0.00 | $30,861.60 |
DisclosureSEC source: 0001022079-17-000184 · wf-form4_150715095923757.xml · derivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,867.491 Underlying: Common Stock · 330 shares Expires not disclosed F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F2 · balance_after: Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11. Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 22:18 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, President and CEO
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 5,302 | $58.18 Strike: $58.18 | $308,443.85 |
DisclosureSEC source: 0001022079-17-000178 · wf-form4_150534109370130.xml · derivative · entry 6 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,840 Underlying: Common Stock · 5,302 shares Expires 2022-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 3, 2017. F4 · derivative.exercise_date: The options vested in three annual installments beginning with the first on May 1, 2013, the second on May 1, 2014 and the final on May 1, 2015. Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 22:18 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, President and CEO
|
SaleCommon Stock | 5,302 | $108.12 | $573,236.33 |
DisclosureSEC source: 0001022079-17-000178 · wf-form4_150534109370130.xml · nonDerivative · entry 4 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,116 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 3, 2017. F3 · price: This transaction was executed in multiple trades at prices ranging from $108.00 to $108.24. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 22:18 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, President and CEO
|
Exercise / conversionCommon Stock | 5,302 | $58.18 | $308,443.85 |
DisclosureSEC source: 0001022079-17-000178 · wf-form4_150534109370130.xml · nonDerivative · entry 3 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,418 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 3, 2017. Read SEC document |
| September 11, 2017 Filed Sep 13, 2017 22:20 UTC |
STANZIONE DANIELDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 5,221 | $61.23 Strike: $61.23 | $319,655.73 |
DisclosureSEC source: 0001022079-17-000180 · wf-form4_150534119632818.xml · derivative · entry 15 STANZIONE DANIEL · CIK 0001221534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,221 shares Expires 2023-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 3, 2017. F6 · derivative.exercise_date: The options vested in three annual installments beginning with the first on May 21, 2014, the second on May 21, 2015 and the final on May 21, 2016. Read SEC document |
| September 11, 2017 Filed Sep 13, 2017 22:20 UTC |
STANZIONE DANIELDirector
|
Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 5,592 | $61.23 Strike: $61.23 | $342,370.20 |
DisclosureSEC source: 0001022079-17-000180 · wf-form4_150534119632818.xml · derivative · entry 14 STANZIONE DANIEL · CIK 0001221534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,592 shares Expires 2023-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 3, 2017. F6 · derivative.exercise_date: The options vested in three annual installments beginning with the first on May 21, 2014, the second on May 21, 2015 and the final on May 21, 2016. Read SEC document |
| September 11, 2017 Filed Sep 13, 2017 22:20 UTC |
STANZIONE DANIELDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 4,268 | $57.57 Strike: $57.57 | $245,687.42 |
DisclosureSEC source: 0001022079-17-000180 · wf-form4_150534119632818.xml · derivative · entry 13 STANZIONE DANIEL · CIK 0001221534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,268 shares Expires 2022-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 3, 2017. F5 · derivative.exercise_date: The options vested in three annual installments beginning with the first on May 11, 2013, the second on May 11, 2014 and the final on May 11, 2015. Read SEC document |
| September 11, 2017 Filed Sep 13, 2017 22:20 UTC |
STANZIONE DANIELDirector
|
Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 5,592 | $57.57 Strike: $57.57 | $321,903.48 |
DisclosureSEC source: 0001022079-17-000180 · wf-form4_150534119632818.xml · derivative · entry 12 STANZIONE DANIEL · CIK 0001221534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,592 shares Expires 2022-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 3, 2017. F5 · derivative.exercise_date: The options vested in three annual installments beginning with the first on May 11, 2013, the second on May 11, 2014 and the final on May 11, 2015. Read SEC document |
| September 11, 2017 Filed Sep 13, 2017 22:20 UTC |
STANZIONE DANIELDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 5,592 | $57.67 Strike: $57.67 | $322,462.68 |
DisclosureSEC source: 0001022079-17-000180 · wf-form4_150534119632818.xml · derivative · entry 11 STANZIONE DANIEL · CIK 0001221534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,592 shares Expires 2021-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 3, 2017. F4 · derivative.exercise_date: The options vested in three annual installments beginning with the first on May 17, 2012, the second on May 17, 2013 and the final on May 17, 2014. Read SEC document |
| September 11, 2017 Filed Sep 13, 2017 22:20 UTC |
STANZIONE DANIELDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 7,319 | $55.76 Strike: $55.76 | $408,107.44 |
DisclosureSEC source: 0001022079-17-000180 · wf-form4_150534119632818.xml · derivative · entry 10 STANZIONE DANIEL · CIK 0001221534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,319 shares Expires 2020-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 3, 2017. F3 · derivative.exercise_date: The options vested in three annual installments beginning with the first on May 16, 2011, the second on May 6, 2012 and the final on May 6, 2013. Read SEC document |
| September 11, 2017 Filed Sep 13, 2017 22:20 UTC |
STANZIONE DANIELDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 7,316 | $51.55 Strike: $51.55 | $377,139.80 |
DisclosureSEC source: 0001022079-17-000180 · wf-form4_150534119632818.xml · derivative · entry 9 STANZIONE DANIEL · CIK 0001221534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,316 shares Expires 2019-05-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 3, 2017. F2 · derivative.exercise_date: The options vested in three annual installments beginning with the first on May 14, 2010, the second on May 14, 2011 and the final on May 14, 2012. Read SEC document |
| September 11, 2017 Filed Sep 13, 2017 22:20 UTC |
STANZIONE DANIELDirector
|
SaleCommon Stock | 40,900 | $108.07 | $4,419,940.30 |
DisclosureSEC source: 0001022079-17-000180 · wf-form4_150534119632818.xml · nonDerivative · entry 8 STANZIONE DANIEL · CIK 0001221534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,675 Read SEC document |
| September 11, 2017 Filed Sep 13, 2017 22:20 UTC |
STANZIONE DANIELDirector
|
Exercise / conversionCommon Stock | 5,592 | $61.23 | $342,370.20 |
DisclosureSEC source: 0001022079-17-000180 · wf-form4_150534119632818.xml · nonDerivative · entry 7 STANZIONE DANIEL · CIK 0001221534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,575 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 11, 2017 Filed Sep 13, 2017 22:20 UTC |
STANZIONE DANIELDirector
|
Exercise / conversionCommon Stock | 5,592 | $57.57 | $321,903.48 |
DisclosureSEC source: 0001022079-17-000180 · wf-form4_150534119632818.xml · nonDerivative · entry 6 STANZIONE DANIEL · CIK 0001221534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,983 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 11, 2017 Filed Sep 13, 2017 22:20 UTC |
STANZIONE DANIELDirector
|
Exercise / conversionCommon Stock | 5,221 | $61.23 | $319,655.73 |
DisclosureSEC source: 0001022079-17-000180 · wf-form4_150534119632818.xml · nonDerivative · entry 5 STANZIONE DANIEL · CIK 0001221534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,391 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 11, 2017 Filed Sep 13, 2017 22:20 UTC |
STANZIONE DANIELDirector
|
Exercise / conversionCommon Stock | 4,268 | $57.57 | $245,687.42 |
DisclosureSEC source: 0001022079-17-000180 · wf-form4_150534119632818.xml · nonDerivative · entry 4 STANZIONE DANIEL · CIK 0001221534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,170 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 11, 2017 Filed Sep 13, 2017 22:20 UTC |
STANZIONE DANIELDirector
|
Exercise / conversionCommon Stock | 5,592 | $57.67 | $322,462.68 |
DisclosureSEC source: 0001022079-17-000180 · wf-form4_150534119632818.xml · nonDerivative · entry 3 STANZIONE DANIEL · CIK 0001221534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,902 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 11, 2017 Filed Sep 13, 2017 22:20 UTC |
STANZIONE DANIELDirector
|
Exercise / conversionCommon Stock | 7,319 | $55.76 | $408,107.44 |
DisclosureSEC source: 0001022079-17-000180 · wf-form4_150534119632818.xml · nonDerivative · entry 2 STANZIONE DANIEL · CIK 0001221534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,310 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 11, 2017 Filed Sep 13, 2017 22:20 UTC |
STANZIONE DANIELDirector
|
Exercise / conversionCommon Stock | 7,316 | $51.55 | $377,139.80 |
DisclosureSEC source: 0001022079-17-000180 · wf-form4_150534119632818.xml · nonDerivative · entry 1 STANZIONE DANIEL · CIK 0001221534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,991 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 11, 2017 Filed Sep 13, 2017 22:18 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, President and CEO
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 53,933 | $58.18 Strike: $58.18 | $3,137,552.28 |
DisclosureSEC source: 0001022079-17-000178 · wf-form4_150534109370130.xml · derivative · entry 5 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,142 Underlying: Common Stock · 53,933 shares Expires 2022-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 3, 2017. F4 · derivative.exercise_date: The options vested in three annual installments beginning with the first on May 1, 2013, the second on May 1, 2014 and the final on May 1, 2015. Read SEC document |
| September 11, 2017 Filed Sep 13, 2017 22:18 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, President and CEO
|
SaleCommon Stock | 53,933 | $108.16 | $5,833,609.01 |
DisclosureSEC source: 0001022079-17-000178 · wf-form4_150534109370130.xml · nonDerivative · entry 2 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,116 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 3, 2017. F2 · price: This transaction was executed in multiple trades at prices ranging from $108.00 to $108.53. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 11, 2017 Filed Sep 13, 2017 22:18 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, President and CEO
|
Exercise / conversionCommon Stock | 53,933 | $58.18 | $3,137,552.28 |
DisclosureSEC source: 0001022079-17-000178 · wf-form4_150534109370130.xml · nonDerivative · entry 1 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,049 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 3, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.